It's Fusion As Jazz Pharmaceuticals, Azur Pharma Reach Merger Agreement
This article was originally published in The Pink Sheet Daily
Executive Summary
The maker of narcolepsy drug Xyrem gets a portfolio of CNS and women's health drugs while moving its headquarters to Ireland, saving millions on taxes.